1. Home
  2. KEQU vs PYPD Comparison

KEQU vs PYPD Comparison

Compare KEQU & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$37.12

Market Cap

97.9M

Sector

Industrials

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.45

Market Cap

86.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
PYPD
Founded
1906
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.9M
86.6M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
KEQU
PYPD
Price
$37.12
$4.45
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$12.25
AVG Volume (30 Days)
3.2K
55.7K
Earning Date
03-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.70
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$2.44
52 Week High
$60.89
$5.12

Technical Indicators

Market Signals
Indicator
KEQU
PYPD
Relative Strength Index (RSI) 57.60 49.08
Support Level $37.04 $4.26
Resistance Level $41.26 $5.05
Average True Range (ATR) 0.87 0.19
MACD 0.41 -0.00
Stochastic Oscillator 74.62 41.67

Price Performance

Historical Comparison
KEQU
PYPD

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: